2024 Supplemental Report Q2 Quarterly Statement
STATEMENT AS OF
ASSETS
Current Statement Date |
4 |
|||||
1 |
2 |
3 |
|
|||
Net Admitted Assets |
Prior Year Net |
|||||
Assets |
Nonadmitted Assets |
(Cols. 1 - 2) |
Admitted Assets |
|||
1. |
Bonds |
............ 7,948,137,965 |
................................... |
............ |
7,948,137,965 |
............ 8,371,150,828 |
2. |
Stocks: |
|||||
2.1 Preferred stocks |
................................... |
................................... |
................................... |
................................... |
||
2.2 Common stocks |
486,882,248 |
................................... |
............... |
486,882,248 |
................490,369,360 |
3. Mortgage loans on real estate:
3.1 First liens |
1,259,883,185 |
................................... |
1,259,883,185 |
1,314,850,716 |
|||
3.2 Other than first liens |
................................... |
................................... |
................................... |
................................... |
|||
4. |
Real estate: |
||||||
4.1 Properties occupied by the company (less $ |
|||||||
encumbrances) |
70,582,348 |
................................... |
70,582,348 |
72,173,765 |
|||
4.2 Properties held for the production of income (less |
|||||||
$ |
encumbrances) |
................................... |
................................... |
................................... |
................................... |
||
4.3 Properties held for sale (less $ |
|||||||
.......................................................................................encumbrances) |
................................... |
................................... |
................................... |
................................... |
|||
5. |
Cash ($ |
217,773,905 ), cash equivalents |
|||||
($ |
1,522,377,802 |
) and short-term |
|||||
investments ($ |
) |
1,740,151,707 |
................................... |
1,740,151,707 |
2,121,399,403 |
||
6. |
Contract loans (including $ |
................................... premium notes) |
889,733,616 |
292,048 |
889,441,568 |
857,623,810 |
|
7. |
Derivatives |
5,998,894,210 |
................................... |
5,998,894,210 |
4,857,567,920 |
||
8. |
Other invested assets |
26,340,507 |
1,698,201 |
24,642,306 |
10,812,755 |
||
9. |
Receivables for securities |
143,609,272 |
................................... |
143,609,272 |
142,059,219 |
||
10. |
Securities lending reinvested collateral assets |
................................... |
................................... |
................................... |
................................... |
||
11. |
Aggregate write-ins for invested assets |
................................... |
................................... |
................................... |
................................... |
||
12. |
Subtotals, cash and invested assets (Lines 1 to 11) |
18,564,215,058 |
1,990,249 |
18,562,224,809 |
18,238,007,776 |
||
13. |
Title plants less $ |
charged off (for Title insurers |
|||||
only) |
................................... |
................................... |
................................... |
................................... |
|||
14. |
Investment income due and accrued |
96,085,742 |
................................... |
96,085,742 |
94,806,527 |
15. Premiums and considerations:
15.1 |
Uncollected premiums and agents' balances in the course of collection |
5,629,820 |
58,691 |
5,571,129 |
5,636,761 |
|
15.2 |
Deferred premiums, agents' balances and installments booked but |
|||||
...................................deferred and not yet due (including $ |
||||||
earned but unbilled premiums) |
................................... |
................................... |
................................... |
................................... |
||
15.3 |
Accrued retrospective premiums ($ |
) and |
||||
contracts subject to redetermination ($ |
) |
................................... ................................... ................................... ................................... |
16. Reinsurance:
....................................................16.1 Amounts recoverable from reinsurers |
................122,175,609 |
................................... |
................122,175,609 |
................123,154,187 |
||
16.2 Funds held by or deposited with reinsured companies |
................................... |
................................... |
................................... |
................................... |
||
16.3 Other amounts receivable under reinsurance contracts |
................................... |
................................... |
................................... |
................................... |
||
17. |
Amounts receivable relating to uninsured plans |
................................... |
................................... |
................................... |
................................... |
|
18.1 |
....Current federal and foreign income tax recoverable and interest thereon |
................409,987,194 |
................................... |
................409,987,194 |
................228,157,127 |
|
18.2 |
Net deferred tax asset |
................................................................................... |
................288,466,017 |
...................... 285,670 |
................288,180,347 |
................398,755,580 |
19. |
Guaranty funds receivable or on deposit |
................. 29,407,326 |
................................... |
................. 29,407,326 |
................. 29,407,326 |
|
20. |
Electronic data processing equipment and software |
................. 34,911,801 |
................. 34,911,801 |
................................... |
................................... |
|
21. |
Furniture and equipment, including health care delivery assets |
|||||
($ |
) |
........................ 12,250 |
........................ 12,250 |
................................... |
................................... |
|
22. |
.........Net adjustment in assets and liabilities due to foreign exchange rates |
................................... |
................................... |
................................... |
................................... |
|
23. |
Receivables from parent, subsidiaries and affiliates |
................. 42,082,436 |
................................... |
................. 42,082,436 |
................. 42,904,605 |
|
24. |
Health care ($ |
) and other amounts receivable |
................................... |
................................... |
................................... |
................................... |
25. |
Aggregate write-ins for other than invested assets |
............ 5,122,489,825 |
...................1,598,485 |
............ 5,120,891,340 |
............ 4,623,678,637 |
|
26. |
Total assets excluding Separate Accounts, Segregated Accounts and |
|||||
Protected Cell Accounts (Lines 12 to 25) |
.......... 24,715,463,078 |
................. 38,857,146 |
.......... 24,676,605,932 |
.......... 23,784,508,526 |
27. From Separate Accounts, Segregated Accounts and Protected Cell
Accounts |
85,957,223,317 |
................................... |
85,957,223,317 |
81,332,932,322 |
|
28. |
Total (Lines 26 and 27) |
110,672,686,395 |
38,857,146 |
110,633,829,249 |
105,117,440,848 |
DETAILS OF WRITE-INS |
|||||
1101. |
...................................................................................................................... |
.................................... |
.................................... |
.................................... |
.................................... |
1102. |
...................................................................................................................... |
.................................... |
.................................... |
.................................... |
.................................... |
1103. |
...................................................................................................................... |
.................................... |
.................................... |
.................................... |
.................................... |
1198. |
Summary of remaining write-ins for Line 11 from overflow page |
................................... |
................................... |
................................... |
................................... |
1199. |
Totals (Lines 1101 through 1103 plus 1198)(Line 11 above) |
||||
2501. |
Derivative collateral |
............ 2,608,955,838 |
................................... |
............ 2,608,955,838 |
............ 2,373,147,654 |
2502. |
Net deferred losses from variable annuity hedge |
............ 2,317,581,668 |
................................... |
............ 2,317,581,668 |
............ 2,053,806,791 |
2503. |
Business owned life insurance |
................109,381,404 |
................................... |
................109,381,404 |
................109,619,783 |
2598. |
Summary of remaining write-ins for Line 25 from overflow page |
................. 86,570,915 |
...................1,598,485 |
................. 84,972,430 |
................. 87,104,409 |
2599. |
Totals (Lines 2501 through 2503 plus 2598)(Line 25 above) |
5,122,489,825 |
1,598,485 |
5,120,891,340 |
4,623,678,637 |
2
STATEMENT AS OF
LIABILITIES, SURPLUS AND OTHER FUNDS
1 |
2 |
|||||
Current |
|
|||||
Statement Date |
Prior Year |
|||||
1. |
Aggregate reserve for life contracts $ |
.......... 11,283,502,326 |
less $ |
included in Line 6.3 |
||
(including $ |
Modco Reserve) |
11,283,502,326 |
11,414,960,358 |
|||
2. |
Aggregate reserve for accident and health contracts (including $ |
Modco Reserve) |
3,050,726,037 |
3,064,920,146 |
||
3. |
Liability for deposit-type contracts (including $ |
Modco Reserve) |
57,930,778 |
40,059,588 |
||
4. |
Contract claims: |
|||||
4.1 Life |
43,956,304 |
53,813,934 |
||||
4.2 Accident and health |
17,755,286 |
18,759,801 |
||||
5. |
Policyholders' dividends/refunds to members $ |
and coupons $ |
due |
|||
and unpaid |
................................... |
................................... |
6. Provision for policyholders' dividends, refunds to members and coupons payable in following calendar year - estimated amounts:
6.1 Policyholders' dividends and refunds to members apportioned for payment (including $ ...................................
|
................................... |
................................... |
|||
6.2 |
Policyholders' dividends and refunds to members not yet apportioned (including $ |
|
................................... |
||
6.3 |
Coupons and similar benefits (including $ |
|
................................... |
||
7. |
Amount provisionally held for deferred dividend policies not included in Line 6 |
................................... |
|||
8. |
Premiums and annuity considerations for life and accident and health contracts received in advance less |
||||
$ |
................................... discount; including $ |
3,079,865 accident and health premiums |
...................5,102,640 |
................... 5,240,330 |
9. Contract liabilities not included elsewhere:
9.1 |
Surrender values on canceled contracts |
................................... |
................................... |
|||
9.2 |
Provision for experience rating refunds, including the liability of $ |
................................... accident and health |
||||
experience rating refunds of which $ |
is for medical loss ratio rebate per the Public Health |
|||||
Service Act |
1,215,300 |
1,419,100 |
||||
9.3 Other amounts payable on reinsurance, including $ |
assumed and $ |
................. 31,833,891 |
||||
ceded |
31,833,891 |
35,558,544 |
||||
9.4 Interest Maintenance Reserve |
................................... |
................................... |
||||
10. |
Commissions to agents due or accrued-life and annuity contracts $ |
................................... , accident and health |
||||
$ |
................................... |
and deposit-type contract funds $ |
............................. 259 |
.................................7 |
||
11. |
..............................................................................Commissions and expense allowances payable on reinsurance assumed |
................................... |
................................... |
|||
12. |
............................................................................................................................................General expenses due or accrued |
................. 16,290,049 |
................. 21,479,394 |
|||
13. |
Transfers to Separate Accounts due or accrued (net) (including $ |
(2,280,388,237) accrued for expense |
||||
allowances recognized in reserves, net of reinsured allowances) |
...........(2,193,006,873) |
.......... (2,279,236,264) |
||||
14. |
Taxes, licenses and fees due or accrued, excluding federal income taxes |
................. 28,009,025 |
................. 31,115,592 |
|||
15.1 Current federal and foreign income taxes, including $ |
on realized capital gains (losses) |
................................... |
................................... |
|||
15.2 |
Net deferred tax liability |
................................... |
................................... |
|||
16. |
Unearned investment income |
................... 2,316,959 |
................... 2,345,017 |
|||
17. |
.......................................................................................Amounts withheld or retained by reporting entity as agent or trustee |
...................8,208,429 |
...................6,895,519 |
|||
18. |
Amounts held for agents' account, including $ |
agents' credit balances |
................................... |
................................... |
||
19. |
........................................................................................................................................Remittances and items not allocated |
................116,754,680 |
................. 91,556,564 |
|||
20. |
Net adjustment in assets and liabilities due to foreign exchange rates |
.................................................................................... |
................................... |
................................... |
||
21. |
.......................................................................................Liability for benefits for employees and agents if not included above |
................................... |
................................... |
|||
22. |
Borrowed money $ |
200,000,000 and interest thereon $ |
................. 10,161,106 |
............... 210,161,106 |
................210,179,333 |
|
23. |
.......................................................................................................................Dividends to stockholders declared and unpaid |
................................... |
................................... |
|||
24. |
Miscellaneous liabilities: |
|||||
...................................................................................................................................................24.01 Asset valuation reserve |
................. 34,137,632 |
................. 35,549,915 |
||||
24.02 Reinsurance in unauthorized and certified ($ |
) companies |
................................... |
................................... |
|||
24.03 Funds held under reinsurance treaties with unauthorized and certified ($ |
) reinsurers |
................................... |
................................... |
|||
24.04 Payable to parent, subsidiaries and affiliates |
..................72,237,772 |
................. 65,967,479 |
||||
...........................................................................................................................................................24.05 Drafts outstanding |
................................... |
................................... |
||||
............................................................................................................24.06 Liability for amounts held under uninsured plans |
................................... |
................................... |
||||
........................................................................................................................................24.07 Funds held under coinsurance |
................................... |
................................... |
||||
24.08 Derivatives |
............ 7,193,199,741 |
............ 5,817,963,622 |
||||
24.09 Payable for securities |
................874,167,016 |
................904,230,729 |
||||
.........................................................................................................................................24.10 Payable for securities lending |
................................... |
................................... |
||||
24.11 Capital notes $ |
and interest thereon $ |
................................... ........................................... |
................................... |
................................... |
||
25. |
Aggregate write-ins for liabilities |
1,258,989,002 |
1,186,580,992 |
|||
26. |
Total liabilities excluding Separate Accounts business (Lines 1 to 25) |
..................................................................................... |
22,113,487,359 |
20,729,359,700 |
||
27. |
From Separate Accounts Statement |
85,956,880,104 |
81,330,955,035 |
|||
28. |
Total liabilities (Lines 26 and 27) |
108,070,367,463 |
102,060,314,735 |
|||
29. |
Common capital stock |
3,000,000 |
3,000,000 |
|||
30. |
..............................................................................................................................................................Preferred capital stock |
................................... |
................................... |
|||
31. |
..........................................................................................................Aggregate write-ins for other than special surplus funds |
................................... |
................................... |
|||
32. |
............................................................................................................................................................................Surplus notes |
............... 500,000,000 |
............... 500,000,000 |
|||
33. |
Gross paid in and contributed surplus |
650,731,922 |
1,050,731,922 |
|||
34. |
Aggregate write-ins for special surplus funds |
2,347,219,914 |
2,085,017,230 |
|||
35. |
Unassigned funds (surplus) |
(937,490,050) |
(581,623,039) |
36. Less treasury stock, at cost:
36.1 |
shares common (value included in Line 29 |
$ |
................................... ) |
................................... |
................................... |
||
36.2 |
shares preferred (value included in Line 30 |
$ |
................................... ) |
................................... |
................................... |
||
37. |
Surplus (Total Lines 31+32+33+34+35-36) (including $ |
343,213 |
in Separate Accounts Statement) |
2,560,461,786 |
3,054,126,113 |
||
38. |
Totals of Lines 29, 30 and 37 |
................................................................................................................................................... |
2,563,461,786 |
3,057,126,113 |
|||
39. |
Totals of Lines 28 and 38 (Page 2, Line 28, Col. 3) |
110,633,829,249 |
105,117,440,848 |
||||
DETAILS OF WRITE-INS |
|||||||
2501. |
Derivative collateral |
............ 1,258,930,980 |
............ 1,186,535,083 |
||||
2502. |
Miscellaneous liabilities |
........................ 58,022 |
........................ 45,909 |
||||
2503 |
.................................... |
.................................... |
|||||
2598. |
..............................................................................................Summary of remaining write-ins for Line 25 from overflow page |
................................... |
................................... |
||||
2599. |
Totals (Lines 2501 through 2503 plus 2598)(Line 25 above) |
1,258,989,002 |
1,186,580,992 |
||||
3101 |
.................................... |
.................................... |
3102 |
.................................... |
.................................... |
|
3103 |
.................................... |
.................................... |
|
3198. |
Summary of remaining write-ins for Line 31 from overflow page |
................................... |
................................... |
3199. |
Totals (Lines 3101 through 3103 plus 3198)(Line 31 above) |
||
3401. |
Surplus from variable annuity hedge |
2,317,581,668 |
2,053,806,791 |
3402. |
Surplus from admitted disallowed IMR |
................. 29,638,246 |
................. 31,210,439 |
3403 |
.................................... |
.................................... |
|
3498. |
Summary of remaining write-ins for Line 34 from overflow page |
................................... |
................................... |
3499. |
Totals (Lines 3401 through 3403 plus 3498)(Line 34 above) |
2,347,219,914 |
2,085,017,230 |
3
STATEMENT AS OF
SUMMARY OF OPERATIONS
1 |
2 |
3 |
||
Current Year |
Prior Year |
Prior Year Ended |
||
To Date |
To Date |
|
||
1. |
Premiums and annuity considerations for life and accident and health contracts |
............ 3,022,958,505 |
............ 2,294,114,602 |
............ 4,973,784,625 |
2. |
Considerations for supplementary contracts with life contingencies |
|||
................................... |
................................... |
................................... |
||
3. |
Net investment income |
................380,691,216 |
................524,221,007 |
................915,308,649 |
4. |
Amortization of Interest Maintenance Reserve (IMR) |
................. (7,941,172) |
................. (4,296,902) |
................(11,872,403) |
5. |
Separate Accounts net gain from operations excluding unrealized gains or losses |
..............(515,933,925) |
..............(480,067,821) |
..............(478,397,026) |
6. |
Commissions and expense allowances on reinsurance ceded |
................. 27,601,771 |
................. 27,936,708 |
................. 57,026,904 |
7. |
Reserve adjustments on reinsurance ceded |
................................... |
................................... |
................................... |
8. |
Miscellaneous Income: |
|||
8.1 Income from fees associated with investment management, administration and contract |
||||
guarantees from Separate Accounts |
................765,872,111 |
................760,596,609 |
............ 1,539,809,338 |
|
8.2 Charges and fees for deposit-type contracts |
................................... |
................................... |
................................... |
|
8.3 Aggregate write-ins for miscellaneous income |
262,082,929 |
254,383,619 |
505,918,975 |
|
9. |
Totals (Lines 1 to 8.3) |
3,935,331,435 |
3,376,887,822 |
7,501,579,062 |
10. |
Death benefits |
150,240,238 |
............... 150,886,622 |
................293,812,235 |
11. |
Matured endowments (excluding guaranteed annual pure endowments) |
................................... |
................................... |
................................... |
12. |
Annuity benefits |
................565,297,346 |
................501,037,217 |
................988,715,737 |
13. |
Disability benefits and benefits under accident and health contracts |
............... 118,966,215 |
................112,045,847 |
................231,613,309 |
14. |
Coupons, guaranteed annual pure endowments and similar benefits |
................................... |
................................... |
................................... |
15. |
Surrender benefits and withdrawals for life contracts |
............ 3,232,853,400 |
............ 2,457,757,686 |
............ 5,197,902,550 |
16. |
Group conversions |
................................... |
................................... |
................................... |
17. |
Interest and adjustments on contract or deposit-type contract funds |
.......................207,473 |
...................... 988,125 |
................... 1,223,786 |
18. |
Payments on supplementary contracts with life contingencies |
..........................4,214 |
..........................4,214 |
..........................8,429 |
19. |
Increase in aggregate reserves for life and accident and health contracts |
(145,652,141) |
(265,418,908) |
(281,136,025) |
20. |
Totals (Lines 10 to 19) |
............ 3,921,916,745 |
............ 2,957,300,803 |
............ 6,432,140,021 |
21. |
Commissions on premiums, annuity considerations, and deposit-type contract funds (direct |
|||
business only) |
................235,423,137 |
................207,380,091 |
................426,794,141 |
|
22. |
Commissions and expense allowances on reinsurance assumed |
................................... |
................................... |
................................... |
23. |
General insurance expenses and fraternal expenses |
................195,869,726 |
................201,182,574 |
................393,171,383 |
24. |
Insurance taxes, licenses and fees, excluding federal income taxes |
................. 18,653,122 |
................. 22,083,681 |
................. 48,432,809 |
25. |
Increase in loading on deferred and uncollected premiums |
.......................(42,300) |
.....................(663,167) |
.....................(707,624) |
26. |
Net transfers to or (from) Separate Accounts net of reinsurance |
..............(834,613,529) |
..............(676,111,406) |
.......... (1,199,415,560) |
27. |
Aggregate write-ins for deductions |
|||
242,699 |
231,800 |
486,398 |
||
28. |
Totals (Lines 20 to 27) |
3,537,449,600 |
2,711,404,376 |
6,100,901,568 |
29. |
Net gain from operations before dividends to policyholders and federal income taxes (Line 9 minus |
|||
Line 28) |
................397,881,835 |
................665,483,446 |
............ 1,400,677,494 |
|
30. |
Dividends to policyholders and refunds to members |
|||
31. |
Net gain from operations after dividends to policyholders, refunds to members and before federal |
|||
income taxes (Line 29 minus Line 30) |
................397,881,835 |
................665,483,446 |
............ 1,400,677,494 |
|
32. |
Federal and foreign income taxes incurred (excluding tax on capital gains) |
6,909,485 |
51,069,606 |
69,353,294 |
33. |
Net gain from operations after dividends to policyholders, refunds to members and federal income |
|||
taxes and before realized capital gains or (losses) (Line 31 minus Line 32) |
................390,972,350 |
................614,413,840 |
............ 1,331,324,200 |
34. Net realized capital gains (losses) (excluding gains (losses) transferred to the IMR) less capital
gains tax of $ |
(189,691,358) (excluding taxes of $ |
(1,693,020) |
||||
transferred to the IMR) |
(713,600,822) |
(370,883,432) |
(486,685,664) |
|||
35. |
Net income (Line 33 plus Line 34) |
(322,628,472) |
243,530,408 |
844,638,536 |
||
CAPITAL AND SURPLUS ACCOUNT |
||||||
36. |
Capital and surplus, |
3,057,126,113 |
3,089,621,377 |
3,089,621,377 |
||
37. |
Net income (Line 35) |
(322,628,472) |
243,530,408 |
844,638,536 |
||
38. |
Change in net unrealized capital gains (losses) less capital gains tax of $ |
.............. 74,931,802 |
276,392,121 |
(203,777,057) |
(223,941,206) |
|
39. |
Change in net unrealized foreign exchange capital gain (loss) |
(10,386,165) |
(5,409,402) |
(3,427,683) |
||
40. |
Change in net deferred income tax |
(38,824,275) |
(36,941,967) |
(158,027,618) |
||
41. |
............................................................................................................Change in nonadmitted assets |
.......................370,181 |
................(47,489,867) |
................130,493,685 |
||
42. |
.......................................Change in liability for reinsurance in unauthorized and certified companies |
................................... |
................................... |
................................... |
||
43. |
..........................Change in reserve on account of change in valuation basis, (increase) or decrease |
................................... |
................................... |
................................... |
||
44. |
Change in asset valuation reserve |
1,412,283 |
(15,453,470) |
(22,230,978) |
||
45. |
Change in treasury stock |
................................... |
................................... |
................................... |
||
46. |
.........................................Surplus (contributed to) withdrawn from Separate Accounts during period |
..............(514,299,851) |
..............(175,624,066) |
..............(175,617,403) |
||
47. |
................................................................Other changes in surplus in Separate Accounts Statement |
............... 514,299,851 |
................175,624,066 |
................175,617,403 |
||
48. |
Change in surplus notes |
................................... |
................................... |
................................... |
||
49. |
Cumulative effect of changes in accounting principles |
................................... |
................................... |
................................... |
||
50. |
Capital changes: |
|||||
50.1 Paid in |
................................... |
................................... |
................................... |
|||
..................................................................................50.2 Transferred from surplus (Stock Dividend) |
................................... |
................................... |
................................... |
|||
..................................................................................................................50.3 Transferred to surplus |
................................... |
................................... |
................................... |
|||
51. |
Surplus adjustment: |
|||||
51.1 Paid in |
(400,000,000) |
(400,000,000) |
(600,000,000) |
|||
........................................................................................51.2 Transferred to capital (Stock Dividend) |
................................... |
................................... |
................................... |
|||
...............................................................................................................51.3 Transferred from capital |
................................... |
................................... |
................................... |
|||
...............................................................................51.4 Change in surplus as a result of reinsurance |
................................... |
................................... |
................................... |
|||
52. |
Dividends to stockholders |
.................................................................................................................... |
................................... |
................................... |
................................... |
|
53. |
.............................................................................Aggregate write-ins for gains and losses in surplus |
|||||
54. |
Net change in capital and surplus for the year (Lines 37 through 53) |
(493,664,327) |
(465,541,355) |
(32,495,264) |
||
55. |
Capital and surplus, as of statement date (Lines 36 + 54) |
2,563,461,786 |
2,624,080,022 |
3,057,126,113 |
||
DETAILS OF WRITE-INS |
||||||
..........................................................................................................................08.301. Miscellaneous income |
............... 262,082,929 |
................254,383,619 |
................505,918,975 |
|||
08.302. |
.............................................................................................................................................................. |
.................................... |
.................................... |
.................................... |
||
08.303. |
.............................................................................................................................................................. |
.................................... |
.................................... |
.................................... |
||
........................................................08.398. Summary of remaining write-ins for Line 8.3 from overflow page |
................................... |
................................... |
................................... |
|||
08.399. Totals (Lines 08.301 through 08.303 plus 08.398) (Line 8.3 above) |
262,082,929 |
254,383,619 |
505,918,975 |
|||
2701. |
Miscellaneous deductions |
................................................................................................................... |
242,699 |
231,800 |
486,398 |
|
2702 |
.................................... |
.................................... |
.................................... |
|||
2703 |
.................................... |
.................................... |
.................................... |
|||
2798. |
.........................................................Summary of remaining write-ins for Line 27 from overflow page |
................................... |
................................... |
................................... |
||
2799. |
Totals (Lines 2701 through 2703 plus 2798)(Line 27 above) |
|||||
242,699 |
231,800 |
486,398 |
||||
5301 |
.................................... |
.................................... |
.................................... |
5302. .............................................................................................................................................................. .................................... .................................... ....................................
5303. .............................................................................................................................................................. .................................... .................................... ....................................
5398. Summary of remaining write-ins for Line 53 from overflow page ............................................................................................ ................................... ...................................
5399. Totals (Lines 5301 through 5303 plus 5398)(Line 53 above)
4
STATEMENT AS OF
CASH FLOW
Cash from Operations
1
Current Year
To Date
2
Prior Year
To Date
3
Prior Year Ended
1. |
Premiums collected net of reinsurance |
............ 3,024,277,431 |
............ 2,297,041,295 |
............ 4,973,596,666 |
|
2. |
Net investment income |
................332,161,215 |
................359,217,909 |
................703,289,149 |
|
3. |
Miscellaneous income |
1,056,617,359 |
1,039,416,890 |
2,102,588,001 |
|
4. |
Total (Lines 1 to 3) |
4,413,056,005 |
3,695,676,094 |
7,779,473,816 |
|
5. |
Benefit and loss related payments |
............ 4,081,177,106 |
............ 3,233,632,500 |
............ 6,705,803,847 |
|
6. |
.................Net transfers to Separate Accounts, Segregated Accounts and Protected Cell Accounts |
..............(768,625,791) |
..............(649,903,507) |
..............(994,162,676) |
|
7. |
...............................................Commissions, expenses paid and aggregate write-ins for deductions |
............... 452,214,051 |
................413,503,378 |
................851,748,767 |
|
8. |
Dividends paid to policyholders |
................................... |
................................... |
................................... |
|
9. |
Federal and foreign income taxes paid (recovered) net of $ |
tax on capital |
|||
gains (losses) |
(2,644,826) |
271,530,729 |
236,774,149 |
||
10. |
Total (Lines 5 through 9) |
3,762,120,540 |
3,268,763,100 |
6,800,164,087 |
|
11. |
Net cash from operations (Line 4 minus Line 10) |
650,935,465 |
426,912,994 |
979,309,729 |
|
Cash from Investments
12. Proceeds from investments sold, matured or repaid:
12.1 |
Bonds |
................231,245,379 |
................553,957,073 |
............ 1,223,462,932 |
|
12.2 |
Stocks |
................... 5,606,017 |
................... 4,898,123 |
................. 86,387,439 |
|
12.3 |
Mortgage loans |
................. 57,276,240 |
................. 51,889,756 |
................. 94,957,683 |
|
12.4 |
Real estate |
................................... |
................................... |
................................... |
|
12.5 |
Other invested assets |
................... 1,164,734 |
...................... 754,865 |
................... 1,921,107 |
|
12.6 |
Net gains or (losses) on cash, cash equivalents and short-term investments |
................... 5,717,815 |
................... 1,519,795 |
.......................678,583 |
|
12.7 |
Miscellaneous proceeds |
175,330,162 |
341,609,553 |
||
12.8 Total investment proceeds (Lines 12.1 to 12.7) |
................301,010,185 |
................788,349,774 |
............ 1,749,017,297 |
||
13. |
Cost of investments acquired (long-term only): |
||||
13.1 |
Bonds |
................172,512,115 |
............... 402,421,661 |
................800,484,673 |
|
13.2 |
Stocks |
................... 7,613,087 |
...................4,904,852 |
................. 12,390,199 |
|
13.3 |
Mortgage loans |
................... 2,308,709 |
................... 4,970,331 |
................. 12,520,331 |
|
13.4 |
Real estate |
................................... |
................................... |
................................... |
|
13.5 |
Other invested assets |
................. 19,500,000 |
................................... |
................................... |
|
13.6 |
Miscellaneous applications |
742,793,524 |
872,154,547 |
1,089,354,395 |
|
13.7 |
Total investments acquired (Lines 13.1 to 13.6) |
944,727,435 |
1,284,451,391 |
1,914,749,598 |
|
14. |
Net increase (or decrease) in contract loans and premium notes |
31,813,792 |
25,270,029 |
61,597,771 |
|
15. |
Net cash from investments (Line 12.8 minus Line 13.7 and Line 14) |
(675,531,042) |
(521,371,646) |
(227,330,072) |
|
Cash from Financing and Miscellaneous Sources |
|||||
16. |
Cash provided (applied): |
||||
16.1 |
Surplus notes, capital notes |
................................... |
................................... |
................................... |
|
16.2 |
Capital and paid in surplus, less treasury stock |
..............(400,000,000) |
..............(400,000,000) |
..............(600,000,000) |
|
16.3 |
Borrowed funds |
................................... |
................................... |
................................... |
|
16.4 |
Net deposits on deposit-type contracts and other insurance liabilities |
................. 17,871,190 |
................. 16,276,459 |
................. 28,343,434 |
|
..........................................................................................................16.5 Dividends to stockholders |
................................... |
................................... |
................................... |
||
....................................................................................................16.6 Other cash provided (applied) |
25,476,691 |
(20,911,985) |
6,389,803 |
||
17. |
Net cash from financing and miscellaneous sources (Line 16.1 through Line 16.4 minus Line 16.5 |
||||
plus Line 16.6) |
(356,652,119) |
(404,635,526) |
(565,266,763) |
||
RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS |
|||||
18. |
.Net change in cash, cash equivalents and short-term investments (Line 11, plus Lines 15 and 17) |
..............(381,247,696) |
..............(499,094,178) |
................186,712,894 |
|
19. |
Cash, cash equivalents and short-term investments: |
||||
19.1 |
Beginning of year |
............ 2,121,399,403 |
............ 1,934,686,509 |
............ 1,934,686,509 |
|
19.2 End of period (Line 18 plus Line 19.1) |
1,740,151,707 |
1,435,592,331 |
2,121,399,403 |
Note: Supplemental disclosures of cash flow information for non-cash transactions:
20.0001. |
Investments contributed |
to separate accounts |
................362,082,722 |
................................... |
................................... |
20.0002. |
Capital contribution to |
subsidiary |
................................... |
........................ 90,428 |
........................ 90,428 |
5
STATEMENT AS OF
EXHIBIT 1
DIRECT PREMIUMS AND DEPOSIT-TYPE CONTRACTS
1 |
2 |
3 |
||
Current Year |
Prior Year |
Prior Year Ended |
||
To Date |
To Date |
|
||
1. |
Individual life |
............... 541,884,122 |
................524,160,733 |
............ 1,075,904,060 |
2. |
Group life |
9,690 |
........................ 10,890 |
........................ 22,168 |
3. |
Individual annuities |
2,527,772,416 |
1,810,340,004 |
3,987,992,717 |
4. |
Group annuities |
16,379,386 |
19,478,413 |
37,482,665 |
5. |
Accident & health |
139,747,023 |
144,255,228 |
294,163,903 |
6. |
Fraternal |
................................... |
................................... |
................................... |
7. |
Other lines of business |
................................... |
................................... |
................................... |
8. |
Subtotal (Lines 1 through 7) |
3,225,792,637 |
2,498,245,268 |
5,395,565,513 |
9. |
Deposit-type contracts |
................. 23,010,407 |
................. 18,456,972 |
................. 33,021,355 |
10. |
Total (Lines 8 and 9) |
3,248,803,044 |
2,516,702,240 |
5,428,586,868 |
6
statement@as@of@june@SPL@RPRT@of@the@rゥカ・イsッオイ」・@lゥヲ・@iョウオイ。ョ」・@cッュー。ョケ
NOTES TO FINANCIAL STATEMENTS
1. Summary of Significant Accounting Policies and Going Concern
- Accounting Practices
The accompanying financial statements ofRiverSource Life Insurance Company ("the Company" or "RiverSource Life") have been prepared in conformity with accounting practices prescribed or permitted by theState of Minnesota Department of Commerce . TheMinnesota Department of Commerce has adopted theNational Association of Insurance Commissioners ("NAIC") Accounting Practices and Procedures Manual as a component of its prescribed statutory accounting principles ("SAP").
A reconciliation of the Company's net income and capital and surplus between NAIC SAP and practices prescribed and permitted by theState of Minnesota is shown below:
F/S |
F/S |
|
|
|||||||||
SSAP # |
Page |
Line # |
2024 |
2023 |
||||||||
NET INCOME/(LOSS): |
||||||||||||
(1) |
The Company's state basis (Page 4, Line 35, Columns 1 & 3) |
XXX |
XXX |
XXX |
$ |
(322,628,472) |
$ |
844,638,536 |
||||
(2) |
State prescribed practices that increase/(decrease) NAIC SAP: None |
- |
- |
|||||||||
(3) |
State permitted practices that increase/(decrease) NAIC SAP: None |
- |
- |
|||||||||
(4) |
NAIC SAP (1-2-3=4) |
XXX |
XXX |
XXX |
$ |
(322,628,472) |
$ |
844,638,536 |
||||
SURPLUS: |
||||||||||||
(5) |
The Company's state basis (Page 3, Line 38, Columns 1 & 2) |
XXX |
XXX |
XXX |
$ |
2,563,461,786 |
$ |
3,057,126,113 |
||||
(6) |
State prescribed practices that increase/(decrease) NAIC SAP: None |
- |
- |
|||||||||
(7) |
State permitted practices that increase/(decrease) NAIC SAP: None |
- |
- |
|||||||||
(8) |
NAIC SAP (5-6-7=8) |
XXX |
XXX |
XXX |
$ |
2,563,461,786 |
$ |
3,057,126,113 |
B. - D. No significant change.
- Accounting Changes and Corrections of ErrorsNone.
- Business Combinations and
Goodwill Not applicable. - Discontinued OperationsNot applicable.
- Investments
A. - C. No significant change.
- Loan-Backedand
Structured Securities ("LBaSS") -
- Prepayment assumptions for LBaSS are based on financial information provided by a licensed data provider. These assumptions are consistent with the current interest rate and economic environment. The retrospective method is used to value LBaSS except in situations where rate changes result in recalculation of the effective yield. The recalculated yield is used to amortize the investment as of the rate change date.
- During the six months ended
June 30, 2024 , the Company had no other-than- temporary impairments ("OTTI") recognized on LBaSS due to intent to sell or inability or lack of intent to retain for a period of time sufficient to recover the amortized cost. - The following table provides information about LBaSS held at
June 30, 2024 for which an OTTI has been recognized in the current reporting period due to the fact that the present value of cash flows expected to be collected is less than the amortized cost of the securities:
Carrying Value |
Present Value of |
Date of Financial |
|||||||||||||||
Before Current |
Projected Cash |
Recognized |
Amortized Cost |
Statement Where |
|||||||||||||
CUSIP |
Period OTTI |
Flows |
OTTI |
After OTTI |
Fair Value |
Reported |
|||||||||||
15136DAC0 |
$ |
1,100,604 |
$ |
951,629 |
$ |
148,975 |
$ |
951,629 |
$ |
749,397 |
|
||||||
15137GAE8 |
880,419 |
703,716 |
176,703 |
703,716 |
319,908 |
|
|||||||||||
19736VAC6 |
3,985,657 |
3,395,438 |
590,219 |
3,395,438 |
2,606,843 |
|
|||||||||||
15136DAC0 |
817,659 |
720,801 |
96,858 |
720,801 |
701,245 |
|
|||||||||||
15137GAE8 |
703,716 |
496,162 |
207,554 |
496,162 |
359,280 |
|
|||||||||||
19736VAC6 |
3,183,774 |
2,762,649 |
421,125 |
2,762,649 |
2,622,089 |
|
|||||||||||
Total |
$ |
1,641,434 |
- The following table provides information about investments in LBaSS for which the carrying value (amortized cost) exceeds fair value and the length of time that individual securities have continuously had amortized cost in excess of fair value, as of
June 30, 2024 :
a. The aggregate amount of unrealized losses:
1. |
Less than 12 Months |
$ |
913,776 |
2. |
12 Months or Longer |
$ |
180,345,033 |
b. The aggregate related fair value of securities with unrealized losses:
1. |
Less than 12 Months |
$ |
117,524,852 |
2. |
12 Months or Longer |
$ |
1,947,658,139 |
For all LBaSS for which carrying value exceeds fair value, RiverSource Life has the intent and ability to retain the investment in the security for a period of time sufficient to recover the carrying value.
-
-
- No change.
- - R. No significant change.
-
- Joint Ventures, Partnerships and Limited Liability CompaniesNo significant change.
- Investment IncomeNo significant change.
- Derivative Instruments
-
- Derivatives underSSAP 86 - Derivatives ("SSAP 86")
(1)-(4) No significant change.
- Derivatives underSSAP 86 - Derivatives ("SSAP 86")
(5)-(7) and (9) Not applicable.
W
statement@as@of@june@SPL@RPRT@of@the@rゥカ・イsッオイ」・@lゥヲ・@iョウオイ。ョ」・@cッュー。ョケ
NOTES TO FINANCIAL STATEMENTS
- The deferred premium associated with certain options is paid or received semiannually over the life of the option contract or at maturity. The following is a summary of the payments the Company is scheduled to make for these options as of
June 30, 2024 :
Derivative Premium |
||
Fiscal Year |
Payments Due |
|
2024 (for the period from |
$ |
68,872,452 |
2025 |
119,082,313 |
|
2026 |
222,575,521 |
|
2027 |
19,545,043 |
|
Thereafter |
361,932,190 |
|
Total future settled premiums |
$ |
792,007,519 |
Derivative Fair Value |
||||||||
with Premium |
Derivative Fair Value |
|||||||
Undiscounted Future |
Commitments |
Excluding |
||||||
Premium |
(Reported on |
Impact of Future Settled |
||||||
Commitments |
Schedule DB) |
Premiums |
||||||
Prior Year - 2023 |
$ |
867,477,586 |
$ |
856,219,260 |
$ |
856,219,260 |
||
Current Year - 2024 |
792,007,519 |
993,255,009 |
993,255,009 |
- Derivatives under SSAP 108 - Derivative Hedging Variable Annuity Guarantees ("SSAP 108")
-
- Discussion of hedged item/hedging instruments and hedging strategy: No significant change.
As discussed in Annual Statement Note 8B(1), due to the Company's modified approach to the calculation of deferred balances, the Company leaves columns 3 through 6 of Schedule DB Part E blank. The following table presents relevant information on the hedged item, based on Company's modified approach:
- Discussion of hedged item/hedging instruments and hedging strategy: No significant change.
Column # |
5 |
6 |
Fair Value Gain (Loss) in Full Contract Cash Flows |
Fair Value Gain (Loss) in Hedged Item |
|
Description in Schedule DB Part E |
Attributed to Interest Rates |
Attributed to Hedged Risk |
RiverSource Life's calculation |
Rho of full contract less Rho of fixed income assets |
Rho of designated hedged risk |
supporting variable annuity reserves |
||
1st Quarter 2024 |
|
|
2nd Quarter 2024 |
|
|
- Recognition of gains/(losses) and deferred assets and liabilities: a. Scheduled Amortization of net gains or (losses):
Amortization Year |
||||||
For the twelve months beginning |
Deferred Assets |
Deferred Liabilities |
||||
1. |
2024 |
$ |
(288,057,680) |
$ |
- |
|
2. |
2025 |
(288,057,680) |
- |
|||
3. |
2026 |
(288,057,680) |
- |
|||
4. |
2027 |
(288,057,680) |
- |
|||
5. |
2028 |
(288,057,680) |
- |
|||
6. |
2029 |
(288,057,680) |
- |
|||
7. |
2030 |
(246,362,246) |
- |
|||
8. |
2031 |
(194,974,627) |
- |
|||
9. |
2032 |
(114,056,811) |
- |
|||
10 |
2033 |
(33,841,904) |
- |
|||
11. |
Total |
$ |
(2,317,581,668) |
$ |
- |
|
b. Total Net Deferred gains/(losses) |
$ |
(2,317,581,668) |
- Reconciliation of Amortization:
1. |
Prior Year |
$ |
(2,053,806,791) |
2. |
Current Year Amortization |
(131,212,373) |
|
3. |
Current Year Deferred Recognition |
394,987,250 |
|
4. |
Ending Net Deferred gains/(losses) [1-(2+3)] |
$ |
(2,317,581,668) |
-
-
- Open Derivative Removed from SSAP 108 and Captured in Scope of SSAP 86: No significant change.
- Open Derivative Removed from SSAP 86 and Captured in Scope of SSAP 108: No significant change.
- Hedging Strategies Identified as No Longer Highly Effective: None.
- Hedging Strategies Terminated: None.
-
- Income Taxes
No significant change. - Information Concerning Parent, Subsidiaries, Affiliates and Other Related Parties
-
- No significant change.
- Cash dividends/distributions paid and received by RiverSource Life were as follows:
Six Months Ended
(in millions)
Paid to |
$ |
400 |
During June of 2024, the Company invested
C. - O. No significant change.
WNQ
statement@as@of@june@SPL@RPRT@of@the@rゥカ・イsッオイ」・@lゥヲ・@iョウオイ。ョ」・@cッュー。ョケ
NOTES TO FINANCIAL STATEMENTS
11. Debt
- No significant change.
- Federal Home Loan Bank Agreements
-
- The Company is a member of the
Federal Home Loan Bank ("FHLB") ofDes Moines which provides access to collateralized borrowings. Members of FHLB ofDes Moines benefit from a range of funding products, the ability to better manage liquidity needs and the opportunity to partner with the FHLB on affordable housing and economic development initiatives. Funding products offered include an overnight fed funds advance, short term (less than 12 months) fixed rate advance, long-term fixed rate advances (1 to 30 years), letters of credit and long- term variable rate advances.
The Company's membership in the FHLB requires the ownership of member stock. The fair value of the assets pledged as collateral by the Company must be maintained at certain specified levels of the borrowed amount, which can vary, depending on the nature of the assets pledged.
The Company borrows short-term funds under these FHLB borrowings. The Company accounts for the liability as a collateralized borrowing, classified in borrowed money. The Company has pledged securities consisting of commercial mortgage backed securities to collateralize its obligation to the FHLB. The securities pledged are reported in bonds. - FHLB Capital Stock a. Aggregate Totals 1.
June 30, 2024
- The Company is a member of the
1 |
2 |
3 |
|||||||||||
Total |
General |
Separate |
|||||||||||
2+3 |
Account |
Accounts |
|||||||||||
(a) |
Membership Stock - Class A |
$ |
- |
$ |
- |
$ |
- |
||||||
(b) |
Membership Stock - Class B |
10,000,000 |
10,000,000 |
- |
|||||||||
(c) |
Activity Stock |
9,000,000 |
9,000,000 |
- |
|||||||||
(d) |
Excess Stock |
- |
- |
- |
|||||||||
(e) |
Aggregate Total |
$ |
19,000,000 |
$ |
19,000,000 |
$ |
- |
||||||
(f) |
Estimated Borrowing Capacity as determined by the Insurer |
$ |
3,884,000,000 |
XXX |
XXX |
||||||||
2. |
|||||||||||||
1 |
2 |
3 |
|||||||||||
Total |
General |
Separate |
|||||||||||
2+3 |
Account |
Accounts |
|||||||||||
(a) |
Membership Stock - Class A |
$ |
- |
$ |
- |
$ |
- |
||||||
(b) |
Membership Stock - Class B |
10,000,000 |
10,000,000 |
- |
|||||||||
(c) |
Activity Stock |
9,000,000 |
9,000,000 |
- |
|||||||||
(d) |
Excess Stock |
- |
- |
- |
|||||||||
(e) |
Aggregate Total |
$ |
19,000,000 |
$ |
19,000,000 |
$ |
- |
||||||
(f) |
Estimated Borrowing Capacity as determined by the Insurer |
$ |
4,025,000,000 |
XXX |
XXX |
- Membership Stock (Class A and B) Eligible and Not Eligible for Redemption
1 |
2 |
Eligible for Redemption |
|||||||||||||
3 |
4 |
5 |
6 |
||||||||||||
Not Eligible |
6 months to |
1 to Less |
|||||||||||||
Current Year |
for |
Less Than 6 |
Less Than 1 |
Than 3 |
3 to 5 |
||||||||||
Membership Stock |
Total |
Redemption |
Months |
year |
Years |
Years |
|||||||||
1. Class A |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
$ |
- |
|||
2. Class B |
10,000,000 |
10,000,000 |
- |
- |
- |
- |
- Collateral Pledged to FHLB
a. Amount Pledged as of Reporting Date
1 |
2 |
3 |
||
Aggregate |
||||
Total |
||||
Fair Value |
Carrying Value |
Borrowing |
||
1. |
Current Year Total General and Separate Accounts |
|||
Total Collateral Pledged (Lines 2+3) |
|
|
|
|
2. |
Current Year General Account Total Collateral Pledged |
328,226,716 |
344,339,016 |
201,411,106 |
3. |
Current Year Separate Accounts Total Collateral Pledged |
768,255,380 |
768,255,380 |
- |
4. |
Prior Year-end Total General and Separate Accounts |
|||
Total Collateral Pledged |
1,060,827,566 |
1,080,111,143 |
201,429,333 |
- Maximum Amount Pledged (based on carrying value) During Reporting Period
123 Amount
Borrowed at |
||||
Time of |
||||
Maximum |
||||
Fair Value |
Carrying Value |
Collateral |
||
1. |
Current Year Total General and Separate Accounts |
|||
Maximum Collateral Pledged (Lines 2+3) |
|
|
|
|
2. |
Current Year General Account Maximum Collateral Pledged |
328,226,716 |
344,339,016 |
201,411,106 |
3. |
Current Year Separate Accounts Maximum Collateral Pledged ... |
768,255,380 |
768,255,380 |
- |
4. |
Prior Year-end Total General and Separate Accounts |
|||
Maximum Collateral Pledged |
1,060,827,566 |
1,080,111,143 |
201,429,333 |
- Borrowing from FHLB
a. Amount as of the Reporting Date 1. Current Year
1 |
2 |
3 |
4 |
||||||||||
Total |
General |
Separate |
Funding Agreements |
||||||||||
2+3 |
Account |
Accounts |
Reserves Established |
||||||||||
(a) |
Debt |
$ |
201,411,106 |
$ |
201,411,106 |
$ |
- |
XXX |
|||||
(b) |
Funding Agreements |
- |
- |
- |
$ |
- |
|||||||
(c) |
Other |
- |
- |
- |
XXX |
||||||||
(d) |
Aggregate Total |
$ |
201,411,106 |
$ |
201,411,106 |
$ |
- |
$ |
- |
||||
WNR
statement@as@of@june@SPL@RPRT@of@the@rゥカ・イsッオイ」・@lゥヲ・@iョウオイ。ョ」・@cッュー。ョケ
NOTES TO FINANCIAL STATEMENTS
2. Prior Year-end |
|||||||||||||
1 |
2 |
3 |
4 |
||||||||||
Total |
General |
Separate |
Funding Agreements |
||||||||||
2+3 |
Account |
Accounts |
Reserves Established |
||||||||||
(a) |
Debt |
$ |
201,429,333 |
$ |
201,429,333 |
$ |
- |
XXX |
|||||
(b) |
Funding Agreements |
- |
- |
- |
$ |
- |
|||||||
(c) |
Other |
- |
- |
- |
XXX |
||||||||
(d) |
Aggregate Total |
$ |
201,429,333 |
$ |
201,429,333 |
$ |
- |
$ |
- |
||||
b. Maximum Amount during Reporting Period (Current Year)
1 |
2 |
3 |
||||||||
Total |
General |
Separate |
||||||||
2+3 |
Account |
Accounts |
||||||||
1. |
Debt |
$ |
201,641,165 |
$ |
201,641,165 |
$ |
- |
|||
2. |
Funding Agreements |
- |
- |
- |
||||||
3. |
Other |
- |
- |
- |
||||||
4. |
Aggregate Total |
$ |
201,641,165 |
$ |
201,641,165 |
$ |
- |
|||
c. FHLB - Prepayment Obligations
Does the Company have prepayment |
||
obligations under the following |
||
arrangements (YES/NO)? |
||
1. |
Debt |
Yes |
2. |
Funding Agreements |
N/A |
3. |
Other |
N/A |
- Retirement Plans, Deferred Compensation, Postemployment Benefits and Compensated Absences and Other Postretirement Benefit PlansNo significant change.
- Capital and Surplus, Dividend Restrictions and Quasi-ReorganizationsNo significant change.
- Liabilities, Contingencies and AssessmentsNo significant change.
- Leases
No significant change. - Information about Financial Instruments with Off-Balance Sheet Risk and Financial Instruments with Concentrations of Credit Risk No significant change.
- Sale, Transfer and Servicing of Financial Assets and Extinguishments of LiabilitiesNo significant change.
- Gain or Loss to the Reporting Entity from Uninsured Plans and the Uninsured Portion of Partially Insured PlansNot applicable.
- Direct Premium Written/Produced by Managing General Agents/Third Party AdministratorsNot applicable.
- Fair Value Measurements
-
- The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company's valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:
Level 1 Unadjusted quoted prices for identical assets or liabilities in active markets that are accessible at the measurement date. Level 2 Prices or valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities. Level 3 Prices or valuations that require inputs that are both significant to the fair value measurement and unobservable.
- The Company categorizes its fair value measurements according to a three-level hierarchy. The hierarchy prioritizes the inputs used by the Company's valuation techniques. A level is assigned to each fair value measurement based on the lowest level input that is significant to the fair value measurement in its entirety. The three levels of the fair value hierarchy are defined as follows:
- Fair Value Measurements at
June 30, 2024
Description for each class of asset |
Net Asset Value |
||||||||||||||||||
or liability |
(Level 1) |
(Level 2) |
(Level 3) |
("NAV") |
Total |
||||||||||||||
a. Assets at fair value |
|||||||||||||||||||
Bonds: Special revenue |
$ |
- |
$ |
2,079,000 |
$ |
- |
$ |
- |
$ |
2,079,000 |
|||||||||
Cash equivalents |
523,813,726 |
- |
- |
- |
523,813,726 |
||||||||||||||
Derivative assets: |
|||||||||||||||||||
Interest rate contracts |
164,253 |
806,854,322 |
- |
- |
807,018,575 |
||||||||||||||
Equity contracts |
31,620,742 |
5,127,660,340 |
- |
- |
5,159,281,082 |
||||||||||||||
Foreign exchange contracts |
126,375 |
32,468,178 |
- |
- |
32,594,553 |
||||||||||||||
Total derivative assets |
31,911,370 |
5,966,982,840 |
- |
- |
5,998,894,210 |
||||||||||||||
Other invested assets |
- |
- |
17,719,333 |
- |
17,719,333 |
||||||||||||||
Separate account assets |
78,999,065 |
12,908,692,527 |
1,033,893,398 |
71,677,908,604 |
85,699,493,594 |
||||||||||||||
Total assets at fair value |
$ |
634,724,161 |
$ |
|
$ |
1,051,612,731 |
$ |
71,677,908,604 |
$ |
92,241,999,863 |
|||||||||
b. Liabilities at fair value |
|||||||||||||||||||
Derivative liabilities: |
|||||||||||||||||||
Interest rate contracts |
$ |
783,400 |
$ |
3,532,206,335 |
$ |
- |
$ |
- |
$ |
3,532,989,735 |
|||||||||
Equity contracts |
109,488,900 |
3,526,750,162 |
- |
- |
3,636,239,062 |
||||||||||||||
Credit contracts |
- |
18,430,000 |
- |
- |
18,430,000 |
||||||||||||||
Foreign exchange contracts |
163,313 |
5,377,631 |
- |
- |
5,540,944 |
||||||||||||||
Total derivative liabilities |
110,435,613 |
7,082,764,128 |
- |
- |
7,193,199,741 |
||||||||||||||
Separate account liabilities |
16,305,788 |
550,547,910 |
- |
- |
566,853,698 |
||||||||||||||
Total liabilities at fair value |
$ |
126,741,401 |
$ |
7,633,312,038 |
$ |
- |
$ |
- |
$ |
7,760,053,439 |
- The following table provides a summary of changes during the current quarter in Level 3 assets and liabilities measured at fair value:
Total gains |
Total gains |
|||||||||||||||||||||||
Beginning |
Transfers |
Transfers out |
and (losses) |
and (losses) |
Ending balance |
|||||||||||||||||||
balance at |
into |
of |
included in |
included in |
Settle- |
at |
||||||||||||||||||
|
Level 3 |
Level 3 |
Net Income |
Surplus |
Purchases |
Issuances |
ments |
2024 |
||||||||||||||||
a. Assets |
||||||||||||||||||||||||
Other invested |
||||||||||||||||||||||||
assets |
$ |
9,559,108 |
$ |
- |
$ |
(5,882,960) (2) |
|
|
|
$ |
- |
$ |
(345,634) |
$ |
17,719,333 |
|||||||||
Separate account |
||||||||||||||||||||||||
assets |
594,502,423 |
980,835 |
(1) |
(25,000,000) (3) |
(155,167) |
- |
408,048,016 |
59,275,000 |
(3,757,709) |
1,033,893,398 |
||||||||||||||
Total assets |
$ |
604,061,531 |
|
$ |
(30,882,960) |
|
|
|
|
$ |
(4,103,343) |
$ |
1,051,612,731 |
-
- Includes bonds transferred to Level 3 as fair value is now based on a single non-binding broker quote.
- Includes other invested assets transferred out of Level 3 as investments are no longer reported at fair value.
- Includes bonds transferred out of Level 3 as fair value is now obtained from a third-party pricing source with observable inputs.
- The Company recognizes transfers between levels of the fair value hierarchy as of the beginning of the quarter in which each transfer occurred.
WNS
Attachments
Disclaimer
Ryan Specialty Announces Promotion of Jason Lentz to President of RT Specialty High Net Worth
5Star Life Insurance Co. recognized on Forbes World’s Best Insurance Companies 2024 List
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News